These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7874762)

  • 1. [An immunohistochemical study on megakaryocytes in patients with myelodysplastic syndromes].
    Liu SQ; Liu XF; Song SJ
    Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):288-90. PubMed ID: 7874762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens.
    Thiele J; Quitmann H; Wagner S; Fischer R
    J Clin Pathol; 1991 Apr; 44(4):300-5. PubMed ID: 2030148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD41 immune staining of micromegakaryocytes improves the diagnosis of myelodysplastic syndrome and differentiation from pancytopenia.
    Huang J; Wang Z; Huang L; Zheng M
    Leuk Res; 2018 Mar; 66():15-19. PubMed ID: 29353154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical micromegakaryocytes, promegakaryoblasts and megakaryoblasts: a critical evaluation by immunohistochemistry, cytochemistry and morphometry of bone marrow trephines in chronic myeloid leukemia and myelodysplastic syndromes.
    Thiele J; Titius BR; Kopsidis C; Fischer R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(5):275-82. PubMed ID: 1279889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of immunocytochemical staining versus Giemsa stain for detecting dysmegakaryopoiesis in myelodysplastic syndromes (MDS).
    Kawaguchi M; Nehashi Y; Aizawa S; Toyama K
    Eur J Haematol; 1990 Feb; 44(2):89-94. PubMed ID: 2318299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of myelodysplastic syndromes and normal bone marrow biopsies with conventional staining and immunocytochemistry.
    Das R; Hayer J; Dey P; Garewal G
    Anal Quant Cytol Histol; 2005 Jun; 27(3):152-6. PubMed ID: 16121636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelodysplastic syndromes: immunohistochemical and morphometric evaluation of proliferative activity in erythropoiesis and endoreduplicative capacity of megakaryocytes.
    Thiele J; Hoffmann I; Bertsch HP; Fischer R
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(1):33-8. PubMed ID: 8105604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Megakaryocytes in myelodysplasia: an immunohistochemical study on bone marrow trephines.
    Fox SB; Lorenzen J; Heryet A; Jones M; Gatter KC; Mason DY
    Histopathology; 1990 Jul; 17(1):69-74. PubMed ID: 1699866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Importance of immunomorphometric evaluation of the size and number of megakaryocytes in normal and pathologic bone marrow].
    Marisavljević D; Rolović Z; Mitrović D
    Srp Arh Celok Lek; 1993; 121(3-7):57-61. PubMed ID: 7716637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on pathophysiology of the myelodysplastic syndromes (MDS)--pattern of dysmegakaryopoiesis related to leukemic transformation].
    Tomonaga M; Jinnai I; Kuriyama K; Nonaka H; Amenomori T; Matsuo T; Yoshida Y; Sasagawa I; Sadamori N; Ichimaru M
    Rinsho Ketsueki; 1989 Oct; 30(10):1788-99. PubMed ID: 2593245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megakaryocytopoiesis and apoptosis in patients with myelodysplastic syndromes.
    Li X; Pu Q
    Leuk Lymphoma; 2005 Mar; 46(3):387-91. PubMed ID: 15621828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic syndrome: diagnostic implications of cytochemical and immunocytochemical studies.
    Seo IS; Li CY; Yam LT
    Mayo Clin Proc; 1993 Jan; 68(1):47-53. PubMed ID: 7678045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megakaryocytopoiesis in bone marrow biopsies of patients with acquired immunodeficiency syndrome (AIDS). An immunohistochemical and morphometric evaluation with special emphasis on myelodysplastic features and precursor cells.
    Thiele J; Titius BR; Quitmann H; Fischer R; Salzberger B; Dienemann D; Stein H
    Pathol Res Pract; 1992 Aug; 188(6):722-8. PubMed ID: 1437834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A megakaryocyte analysis of the bone marrow in patients with myelodysplastic syndrome, myeloproliferative disorder and allied disorders.
    Ohshima K; Kikuchi M; Takeshita M
    J Pathol; 1995 Oct; 177(2):181-9. PubMed ID: 7490685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone marrow histological changes in myelodysplastic syndrome and its clinical significance].
    Liu XF; Wang BM; Yi FH
    Zhonghua Nei Ke Za Zhi; 1991 Nov; 30(11):675-7, 729. PubMed ID: 1815870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on bone marrow megakaryocytes in children patients with myelodysplastic syndrome].
    Shi XD; Hu T; Feng YL; Liu R; Li JH; Wang TY; Chen J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Feb; 12(1):74-8. PubMed ID: 14989774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Megakaryocytic ploidy in myelodysplastic syndromes.
    Kobayashi Y; Ozawa M; Maruo N; Kondo M
    Leuk Lymphoma; 1993 Jan; 9(1-2):55-61. PubMed ID: 8477202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphological analysis of the megakaryocytes in myelodysplastic syndrome].
    Mori H; Niikura H; Terada H; Fujita K
    Rinsho Byori; 1990 Dec; 38(12):1347-52. PubMed ID: 2082033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study about proliferation and apoptosis of megakaryocytes in patients with myelodysplastic syndromes].
    Li X; Pu Q; Liu YZ; Shi J; Tao Y; Chang CK; Jiang QY; Huang W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):40-3. PubMed ID: 12513835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptotic megakaryocyte dysplasia in the myelodysplastic syndromes.
    Hatfill SJ; Fester ED; Steytler JG
    Hematol Pathol; 1992; 6(2):87-93. PubMed ID: 1607344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.